Literature DB >> 33221367

Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.

Nguyen Van Vinh Chau1, Le Mau Toan2, Dinh Nguyen Huy Man2, Huynh Phuong Thao2, Nguyen Phu Huong Lan2, Dinh Thi Bich Ty2, Dinh Khac Hieu2, Nguyen Thi My Tien2, Nghiem My Ngoc2, Le Manh Hung2, Nguyen Thanh Dung2, Tran Tan Thanh3, Nguyen Thanh Truong2, Guy Thwaites4, Le Van Tan5.   

Abstract

Entities:  

Keywords:  COVID-19; Health care workers; SARS-CoV-2; Sero-survey; Seroprevalence

Mesh:

Substances:

Year:  2020        PMID: 33221367      PMCID: PMC7674964          DOI: 10.1016/j.jinf.2020.11.018

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
Dear Editor, Recent reports (including those from this journal) showed the sero-prevalence of SARS-CoV-2 in health care workers worldwide was between 1.2% and 17.4%.1, 2, 3, 4 Such knowledge is essential to assess the effectiveness of infection prevention measures and to minimize the risk of nosocomial infection. In Vietnam, the first cases of coronavirus disease 2019 (COVID-19) were reported on 23rd January 2020. Since then there have been two major COVID-19 epidemic waves attributable to locally acquired infection, one in March/April and the second in July/August. In Ho Chi Minh City (HCMC), by 27th October 2020, 82 PCR confirmed cases of SARS-CoV-2 infection have been reported, with the last cases of the second wave occurring on 2nd August. The Hospital for Tropical Diseases (HTD) in HCMC is a 660-bed tertiary referral hospital for patient with infectious diseases in southern Vietnam (population >40 million). HTD has 700 staff and two designated centres for COVID-19 patients located in the West and the East of HCMC. These two centres and the HTD main campus are run HTD members of staff, and are responsible for receiving and treating COVID-19 patients, especially those with severe infection, in southern Vietnam. As a reference laboratory, HTD is also responsible for SARS-CoV-2 testing in HCMC. By the end of August 2020, nearly 50,000 SARS-CoV-2 PCRs were conducted by the HTD laboratory. During the last week of August, we conducted a sero-survey of SARS-CoV-2 antibodies amongst the HTD staff to assess the risk of nosocomial infection. We invited any hospital staff regardless of their occupations and the nature of their work to participate in the study. We collected demographics, occupation and information about SARS-CoV-2 exposure (caring for COVID-19 patients or conducting SARS-CoV-2 testing). For SARS-CoV-2 antibody measurement, we collected 5 ml plasma from each participant. We measured antibodies against the nucleocapsid (N) protein, a main immunogen of SARS-CoV-2 using Elecsys Anti‑ SARS‑ CoV‑ 2 assay (Roche, Germany). The reported sensitivity and specificity this assay were 97.2% and 99.8% respectively. The institutional review board of HTD approved the clinical study. Of 700 staff of HTD, 408 consented to enroll in the study (56% response rate). The study participants included all 97 staff who provided direct clinical care for COVID-19 patients, and all 34 staff whose work involved in processing respiratory samples from COVID-19 patients. The study participants aged from 20 to 60 years with a median of 32 years. Nurses were predominant, accounting for 35.3% (144/408), followed by medical doctors (64/408, 15.7%) and cleaners (42/408, 10.3%). More details about the characteristics of the study participants are presented in Table 1 . None of the study participants had detectable antibodies against N protein.
Table 1

Characteristics of the study participants.

Demography
Age, y, median (range)32 (20–60)
Sex (female/male), n/n264/144
Type of occupationN = 408
Nurse, n(%)144 (35.3)
Medical doctor, n(%)64 (15.7)
Cleaner, n(%)42 (10.3)
Laboratory staff, n(%)33 (8.1)
Non-lab technician, n(%)22 (5.4)
Data entry clerk, n(%)20 (5.0)
Pharmacist, n(%)17 (4.2)
Maintenance staff, n(%)6 (1.5)
Social worker, n(%)7 (1.7)
Other, n(%)9 (2.2)
Non-specified, n(%)44 (10.8)
Types of SARS-CoV-2 exposureN = 408
Providing care for COVID-19 patients*, n(%)97 (23.8)
Handling respiratory samples from suspected COVID-19 patients, n (%)34 (8.3)
No, n (%)277 (67.9)
Fields of occupationN = 15
COVID-19 patient ward, n(%)3 (20)
Non-COVID-19 patient ward, n(%)12 (80)

Note to: *including daily medical examination, performing intubation, taking swabs for follow up PCR diagnosis and facility cleaning.

Characteristics of the study participants. Note to: *including daily medical examination, performing intubation, taking swabs for follow up PCR diagnosis and facility cleaning. Our study did not find evidence of SARS-CoV-2 antibodies in 408 HTD staff, including those providing care for COVID-19 patients or conducting laboratory diagnosis of SARS-CoV-2. The risk of nosocomial infection among health care workers is likely associated with the burden posed by the number admitted COVID-19 patients, especially those requiring mechanical ventilation. Of note, only one COVID-19 patient required mechanical ventilation at HTD since the start of the pandemic. Other contributing factors may include early preparedness and experience gained from previous pandemics. Indeed, as part of COVID-19 response in Vietnam, HTD conducted safety training on COVID-19 patient management and laboratory safety for its designated staff in early January 2020; in advance of the first detection of SARS-CoV-2 in HCMC. To further reduce the risk of nosocomial infection, wearing a medical mask is mandatory for all COVID-19 patients, while being hospitalized. Additionally, many members of the current HTD staff have been frontline health care workers of several emerging infections over the last decades, including SARS in 2003, avian influenza A virus subtype H5N1 in 2004, pandemic flu caused by influenza A virus subtype H1N1 in 2009, and the current COVID-19 pandemic. Notably, previous surveillance did not find evidence of antibodies against SARS or avian influenza A virus subtype H5N1 in frontline health care workers in Vietnam. , Seasonal coronaviruses (OC43, NL63, HKU1 and 229E) are common causes of respiratory infection worldwide with seroprevalence increasing with age. It is likely that past infection with these coronaviruses might have occurred in a certain proportion of the study participants. Thus the results point to the potential of non-cross-reactivity between antibodies against these seasonal coronaviruses and the N protein of SARS-CoV-2 in the study participants. The extent to which sera collected from Vietnamese people prior to the COVID-19 pandemic could react with or neutralize SARS-CoV-2 merits further research. In summary, antibodies against N protein of SARS-CoV-2 were not detected in 408 (56%) of health care workers of a major hospital for COVID-19 in southern Vietnam. While the results are reassuring, it remains important to conduct regular sero-surveys of SARS-CoV-2 in frontline health care workers to assess the risk of nosocomial infection. Such knowledge remains important to inform the implementation of infection prevention measures in health care settings.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  9 in total

1.  Human coronavirus NL63 and 229E seroconversion in children.

Authors:  Ronald Dijkman; Maarten F Jebbink; Nawal Bahia El Idrissi; Krzysztof Pyrc; Marcel A Müller; Taco W Kuijpers; Hans L Zaaijer; Lia van der Hoek
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

2.  Avian influenza H5N1 and healthcare workers.

Authors:  Constance Schultsz; Vo Cong Dong; Nguyen Van Vinh Chau; Nguyen Thi Hanh Le; Wilina Lim; Tran Tan Thanh; Christiane Dolecek; Menno D de Jong; Tran Tinh Hien; Jeremy Farrar
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

3.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.

Authors:  Johannes Korth; Benjamin Wilde; Sebastian Dolff; Olympia E Anastasiou; Adalbert Krawczyk; Michael Jahn; Sebastian Cordes; Birgit Ross; Stefan Esser; Monika Lindemann; Andreas Kribben; Ulf Dittmer; Oliver Witzke; Anke Herrmann
Journal:  J Clin Virol       Date:  2020-05-13       Impact factor: 3.168

4.  The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Nguyen Van Vinh Chau; Vo Thanh Lam; Nguyen Thanh Dung; Lam Minh Yen; Ngo Ngoc Quang Minh; Le Manh Hung; Nghiem My Ngoc; Nguyen Tri Dung; Dinh Nguyen Huy Man; Lam Anh Nguyet; Le Thanh Hoang Nhat; Le Nguyen Truc Nhu; Nguyen Thi Han Ny; Nguyen Thi Thu Hong; Evelyne Kestelyn; Nguyen Thi Phuong Dung; Tran Chanh Xuan; Tran Tinh Hien; Nguyen Thanh Phong; Tran Nguyen Hoang Tu; Ronald B Geskus; Tran Tan Thanh; Nguyen Thanh Truong; Nguyen Tan Binh; Tang Chi Thuong; Guy Thwaites; Le Van Tan
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

5.  High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.

Authors:  Yuxin Chen; Xin Tong; Jian Wang; Weijin Huang; Shengxia Yin; Rui Huang; Hailong Yang; Yong Chen; Aijun Huang; Yong Liu; Yan Chen; Ling Yuan; Xiaomin Yan; Han Shen; Chao Wu
Journal:  J Infect       Date:  2020-06-04       Impact factor: 6.072

6.  Lack of SARS transmission among public hospital workers, Vietnam.

Authors:  Dang Ha Le; Sharon A Bloom; Quang Hien Nguyen; Susan A Maloney; Quynh Mai Le; Katrin C Leitmeyer; Huy Anh Bach; Mary G Reynolds; Joel M Montgomery; James A Comer; Peter W Horby; Aileen J Plant
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

7.  Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.

Authors:  Kasper Iversen; Henning Bundgaard; Rasmus B Hasselbalch; Jonas H Kristensen; Pernille B Nielsen; Mia Pries-Heje; Andreas D Knudsen; Casper E Christensen; Kamille Fogh; Jakob B Norsk; Ove Andersen; Thea K Fischer; Claus Antonio Juul Jensen; Margit Larsen; Christian Torp-Pedersen; Jørgen Rungby; Sisse B Ditlev; Ida Hageman; Rasmus Møgelvang; Christoffer E Hother; Mikkel Gybel-Brask; Erik Sørensen; Lene Harritshøj; Fredrik Folke; Curt Sten; Thomas Benfield; Susanne Dam Nielsen; Henrik Ullum
Journal:  Lancet Infect Dis       Date:  2020-08-03       Impact factor: 25.071

8.  Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.

Authors:  Laurent Blairon; Saphia Mokrane; Alain Wilmet; Géraldine Dessilly; Benoît Kabamba-Mukadi; Ingrid Beukinga; Marie Tré-Hardy
Journal:  J Infect       Date:  2020-07-31       Impact factor: 6.072

9.  Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.

Authors: 
Journal:  Lancet Infect Dis       Date:  2020-09-23       Impact factor: 25.071

  9 in total
  8 in total

1.  Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.

Authors:  Steven He; Anthony Hecimovic; Vesna Matijasevic; Ha Thi Mai; Linda Heslop; Jann Foster; Kate E Alexander; Naru Pal; Evan Alexandrou; Patricia M Davidson; Steven A Frost
Journal:  J Clin Nurs       Date:  2021-09-27       Impact factor: 4.423

2.  The prevalence of SARS-CoV-2 antibodies in quarantine workers and high-risk communities in Vietnam.

Authors:  Tasnim Hasan; Pham Ngoc Thach; Nguyen Thu Anh; Le Thi Thu Hien; Nguyen Thi Mai An; Dang Thi Thuy; Le Van Duyet; Nguyen Thi Dung; Tran Thi Diep; Hoang Van Huynh; Brett G Toelle; Guy B Marks; Greg J Fox
Journal:  IJID Reg       Date:  2021-12-11

3.  Seroprevalence of hospital staff in a province with zero COVID-19 cases.

Authors:  Tanawin Nopsopon; Krit Pongpirul; Korn Chotirosniramit; Wutichai Jakaew; Chuenkhwan Kaewwijit; Sawan Kanchana; Narin Hiransuthikul
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

4.  An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam.

Authors:  Nguyen Van Vinh Chau; Nghiem My Ngoc; Lam Anh Nguyet; Vo Minh Quang; Nguyen Thi Han Ny; Dao Bach Khoa; Nguyen Thanh Phong; Le Mau Toan; Nguyen Thi Thu Hong; Nguyen Thi Kim Tuyen; Voong Vinh Phat; Le Nguyen Truc Nhu; Nguyen Huynh Thanh Truc; Bui Thi Ton That; Huynh Phuong Thao; Tran Nguyen Phuong Thao; Vo Trong Vuong; Tran Thi Thanh Tam; Ngo Tan Tai; Ho The Bao; Huynh Thi Kim Nhung; Nguyen Thi Ngoc Minh; Nguyen Thi My Tien; Nguy Cam Huy; Marc Choisy; Dinh Nguyen Huy Man; Dinh Thi Bich Ty; Nguyen To Anh; Le Thi Tam Uyen; Tran Nguyen Hoang Tu; Lam Minh Yen; Nguyen Thanh Dung; Le Manh Hung; Nguyen Thanh Truong; Tran Tan Thanh; Guy Thwaites; Le Van Tan
Journal:  EClinicalMedicine       Date:  2021-09-30

5.  Seroprevalence of SARS-CoV-2 Neutralizing Antibodies among Blood Donors in Ho Chi Minh City, Vietnam, August-November 2020.

Authors:  Hanh Hong Ho Nguyen; Quan Hoang Nguyen; Dung Thi Thuy Truong; Manh Huy Dao; Tu Ngoc Le; Hieu Trung Nguyen; Anh Hoang Nguyen; Thinh Viet Nguyen; Dao Thi Nhu Hoang; Loan Kim Hoang; Tham Thi Tran; Thang Minh Cao; Quang Chan Luong; Lan Trong Phan; Loan Thi Kim Huynh; Thuong Vu Nguyen; Quang Duy Pham
Journal:  Am J Trop Med Hyg       Date:  2022-01-26       Impact factor: 3.707

6.  Immunogenicity of Oxford-AstraZeneca COVID-19 Vaccine in Vietnamese Health-Care Workers.

Authors:  Nguyen Van Vinh Chau; Lam Anh Nguyet; Nguyen Thanh Truong; Le Mau Toan; Nguyen Thanh Dung; Le Manh Hung; Mai Thanh Nhan; Dinh Nguyen Huy Man; Nghiem My Ngoc; Huynh Phuong Thao; Tran Nguyen Hoang Tu; Huynh Kim Mai; Do Thai Hung; Nguyen Thi Han Ny; Le Kim Thanh; Nguyen To Anh; Nguyen Thi Thu Hong; Le Nguyen Truc Nhu; Lam Minh Yen; Marc Choisy; Tran Tan Thanh; Guy Thwaites; Le Van Tan
Journal:  Am J Trop Med Hyg       Date:  2022-01-07       Impact factor: 2.345

7.  Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.

Authors:  Tasnim Hasan; Thach Ngoc Pham; Thu Anh Nguyen; Hien Thi Thu Le; Duyet Van Le; Thuy Thi Dang; Trang Dinh Van; Yen Ngoc Pham; Ha Viet Nguyen; Giang Linh Tran; Van Thi Cam Nguyen; Thanh Trung Nguyen; Viet Quang Truong; Than Huu Dao; Chung Thanh Le; Nam Tan Truong; Hoang Trung Vo; Phuc Thanh Le; Thao Thanh Nguyen; Vinh Van Luu; Vinh Dai Nguyen; Brett G Toelle; Guy B Marks; Greg J Fox
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

8.  Did Laos really control the transmission of SARS-CoV-2 in 2020?

Authors:  Barnaby Flower; Michael Marks
Journal:  Lancet Reg Health West Pac       Date:  2021-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.